Abstract
The mucosal immune system is composed of distinct regional immune tissue (e.g., “GALT,” gut-associated lymphoid tissue; “BALT,” bronchus-associated lymphoid tissue; reproductive tract and breast tissue, and so forth) interconnected by trafficking of primed lymphocytes as a common “mucosa-associated lymphoid tissue,” “MALT” (1). In addition, immune responses within MALT may occur independently of systemic immunity, with distinctive regulatory mechanisms and the induction of dimeric secretory IgA (SIgA) at the mucosal surface. As a result traditional methods for inducing systemic immunity may not induce significant SIgA, and techniques have been developed to deliver antigen directly to a mucosal surface in such a way as to induce immunity rather than immunological tolerance. The trafficking of primed B- and T-cells between mucosal sites, probably regulated by specific adhesion molecules, such as α4β7 integrin on lymphocytes and MAdCAM- on mucosal blood vessels (2), leads to dissemination of the mucosal immune response. One benefit of this, therefore, is that immunization of an accessible mucosal surface may induce an immune response at less accessible mucosal sites (such as the genital tract). Furthermore, by characterizing mucosa homing lymphocytes trafficking in the blood, it may be possible to indirectly study mucosal responses.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Czerkmsky, C. and Holmgren, J. (1994) Exploration of mucosal immumty in humans: relevance to vaccine development. Cell. Mol. Biol. 1, 37–44.
Quiding, J. M., Lakew, M., Nordstrom, I., Banchereau, J, Butcher, E., Holmgren, J, and Czerkinsky, C. (1995) Human circulating specific antibody-forming cells after systemic and mucosal immunizations: differential homing commitments and cell surface differentiation markers Eur. J. Immunol. 25 322–327
Holmgren, J., Svennerholm, A. M., Jertborn, M., Clemens, J., Sack, D. A., Salenstedt, R., and Wigzell, H. (1992) An oral B subumt: whole cell vaccine aganist cholera. Vaccine 10, 911–914.
Lewis, D. J., Novotny, P., Dougan, G., and Griffin, G. E. (1991) The early cellular and humoral immune response to primary and booster oral immunization with cholera toxin B subunit. Eur. J. Immunol. 21, 2087–2094
Lewis, D. J., Gilks, C. F., Ojoo, S., Castello, B. L., Dougan, G., Evans, M. R., McDermott, S., and Griffin, G. E. (1994) Immune response following oral administration of cholera toxm B subunit to HIV-l-infected UK and Kenyan subjects. AIDS 8, 779–785.
Eriksson, K., Kilander, A., Hagberg, L., Norkrans, G., Holmgren, J., and Czerkmsky, C. (1993) Intestinal antibody responses to oral vaccination in HIV-Infected individuals AIDS 7, 1087–1091.
Holmgren, J., Lycke, N., and Czerkinsky, C. (1993) Cholera toxin and cholera subunit as oral-mucosal adjuvant and antigen vector systems Vaccine 11, 1179–1184.
Roberts, M., Bacon, A., Rappuoh, R, Pizza, M., Cropley, I., Deuce, G., Dougan, G., Marinaro, M., McGhee, J., and Chatfield, S. (1995) A mutant pertussis toxm molecule that lacks ADP-ribosyltransferase activity, PT-9W129G, is an effective mucosal adjuvant for intranasally delivered proteins. Infect. Immun. 63, 2100–2108.
Deuce, G., Turcotte, C., Cropley, I., Roberts, M., Pizza, M., Domenghmi, M., Rappuoli, R., and Dougan, G. (1995) Mutants of Escherzchza coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc. Natl Acad. Sci. USA 92, 1644–1648.
Bergquist, C., Lagergard, T., Lindblad, M., and Holmgren, J. (1995) Local and systemic antibody responses to dextran-cholera toxin B subunit conjugates. Infect. Immun. 63, 2021–2025.
O’Hagan, D. T., McGee, J. P., Holmgren, J., Mowat, A. M., Donachie, A. M, Mills, K H, Gaisford, W., Rahman, D., and Challacombe, S J (1993) Biodegradable microparticles for oral immunization. Vaccine 11, 149–154.
Chatfield, S., Roberts, M., Li, J., Stains, A., and Dougan, G. (1994) The use of live attenuated Salmonella for oral vaccination. Dev Biol. Standard. 82, 35–42.
Lelmer, T., Tao, L., Panagiotidi, C., Klavmskis, L. S., Brookes, R., Hussam, L., Meyers, N., Adams, S. E., Gearing, A. J., and Bergmeier, L. A. (1994) Mucosal model of genital immunization in male rhesus macaques with a recombiant simian immunodeficiency virus p27 antigen. J. Virol. 68, 1624–1632.
Quiding, J. M., Granstrom, G., Nordstrom, I., Holmgren, J., and Czerkmsky, C. (1995) Induction of compartmentalized B-cell responses in human tonsils. Infect. Immun 63, 853–857.
Cripps, A. W., Dunkley, M. L., and Clancy, R. L. (1994) Mucosal and systemic immunizations with killed Pseudomonas aeruginosa protect against acute respiratory infection in rats. Infect. Immun 62, 1427–1436
Lehner, T., Bergmeier, L. A., Tao, L., Panagiotidt, C., Klavinskis, L. S., Hussam, L, Ward, R. G., Meyers, N., Adams, S. E., Gearing, A. J., et al. (1994) Targeted lymph node immunization with simian immunodeficiency virus p27 antigen to elicit genital, rectal, and urinary immune responses in nonhuman primates. J. Immunol 153, 1858–1868.
Lue, C., van den Wall Bake, A. W., Prince, S. J., Juhan, B. A., Tseng, M. L, Radl, J., Elson, C. O., and Mestecky, J. (1994) Intrapentoneal immunization of human subjects with tetanus toxoid induces specific antibody-secreting cells in the peritoneal cavity and in the circulation, but fails to elicit a secretory IgA response. Clin. Exp. Immunol. 96, 356–363.
Castello-Branco, L. R. R., Griffin, G. E., Poulton, T. A., Dougan, G., and Lewis, D. J. M. (1994) Characterisation of the circulating T cell response after oral lmmunisation of human volunteers with cholera toxin B subunit. Vaccine 12, 65–72.
Castello-Branco, L. R. R., Griffin, G. E., Dougan, G., and Lewis, D. J. M. (1995) A method to screen T lymphocyte epitopes after oral immumsation of humans: application to cholera toxm B subunit. Vaccine 13, 817–820.
Lagoo, A. S., Eldridge, J. H., Lagoo, D. S., Black, A., Ridwan, B. U., Hardy, K. J., McGhee, J. R., and Beagley, K. W. (1994) Peyer’s patch CD8+ memory T cells secrete T helper type 1 and type 2 cytokines and provide help for immunoglobuhn secretion. Eur J, Immunol. 24, 3087–3092.
Hiroi, T., Fujihashi, K., McGhee, J. R., and Kiyono, H. (1994) Characterization of cytokme-producing cells in mucosal effector sites: CD3+ T cells of Thl and Th2 type in salivary gland-associated tissues. Eur. J. Immunol. 24, 2653–2658.
Marcello, A., Loregian, A., Palu, G., and Hirst, T. R. (1994) Efficient extracellular production of hybrid Escherichia colz heat-labile enterotoxin B subunits in a marine vibrio. Ferns Microblol. Lett. 117, 47–51
Hashar, T. H. and Hurst, T. R. (1995) Immunoregulatory role of H-2 and intra-H-2 alleles on antibody responses to recombinant preparations of B-subunits of Escherichia colz heat labile enterotoxin (rEtxB) and cholera toxin (rCtxB). Vaccine 13, 803–810.
Schaefer, M. E., Rhodes, M., Prince, S J., Michalek, S. M., and McGhee, J. R. (1977) A plastic intraoral device for the collection of human parotid saliva. J. Dent. Res. 56, 728–733.
Gaspari, M. M., Brennan, P T., Solomon, S. M., and Elson, O. (1988) A method of obtaining, processing, and analyzing human intestinal secretions for antibody content. J. Immunol. Methods 110, 85–91.
de Vos, T. and Dick, T A. (1991) A rapid method to determine the isotype and specificity of coproantibodies in mice infected with Trichinella or fed cholera toxin J. Immunol. Methods 141, 285–288.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Humana Press Inc, Totowa, NJ
About this protocol
Cite this protocol
Lewis, D.J.M., Hayward, C.M.M. (1996). Stimulation of Mucosal Immunity. In: Robinson, A., Farrar, G.H., Wiblin, C.N. (eds) Vaccine Protocols. Methods in Molecular Medicine™, vol 4. Humana Press. https://doi.org/10.1385/0-89603-334-1:187
Download citation
DOI: https://doi.org/10.1385/0-89603-334-1:187
Publisher Name: Humana Press
Print ISBN: 978-0-89603-334-4
Online ISBN: 978-1-59259-588-4
eBook Packages: Springer Protocols